Elevation Point Wealth Partners LLC Purchases Shares of 2,515 National HealthCare Corporation $NHC

Elevation Point Wealth Partners LLC acquired a new stake in National HealthCare Corporation (NYSEAMERICAN:NHCFree Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 2,515 shares of the company’s stock, valued at approximately $403,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Morgan Stanley Institutional Investment Advisors LLC increased its holdings in National HealthCare by 38.6% during the 4th quarter. Morgan Stanley Institutional Investment Advisors LLC now owns 1,038,787 shares of the company’s stock worth $142,407,000 after purchasing an additional 289,566 shares during the period. M Holdings Securities Inc. acquired a new stake in National HealthCare in the 3rd quarter valued at about $56,283,000. First Trust Advisors LP boosted its stake in shares of National HealthCare by 75.8% in the 4th quarter. First Trust Advisors LP now owns 364,687 shares of the company’s stock valued at $49,995,000 after buying an additional 157,204 shares during the period. Geode Capital Management LLC boosted its stake in shares of National HealthCare by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 318,440 shares of the company’s stock valued at $43,662,000 after buying an additional 2,361 shares during the period. Finally, Goldman Sachs Group Inc. grew its position in shares of National HealthCare by 43.5% during the fourth quarter. Goldman Sachs Group Inc. now owns 85,781 shares of the company’s stock worth $11,760,000 after buying an additional 26,020 shares in the last quarter. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on NHC. BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. Robert W. Baird upgraded shares of National HealthCare to a “strong-buy” rating in a report on Monday, May 18th. Royal Bank Of Canada raised shares of National HealthCare to a “hold” rating in a research report on Monday, May 18th. Finally, The Goldman Sachs Group upgraded shares of National HealthCare to a “strong-buy” rating in a report on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy”.

Check Out Our Latest Report on National HealthCare

National HealthCare Stock Down 2.1%

Shares of NHC opened at $211.78 on Thursday. The stock has a 50 day moving average price of $194.35 and a 200 day moving average price of $168.69. The company has a market capitalization of $3.31 billion, a price-to-earnings ratio of 26.91 and a beta of 0.63. National HealthCare Corporation has a 52-week low of $93.54 and a 52-week high of $220.86.

National HealthCare (NYSEAMERICAN:NHCGet Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $1.91 earnings per share for the quarter. The company had revenue of $381.82 million for the quarter. National HealthCare had a net margin of 8.10% and a return on equity of 9.98%.

National HealthCare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a dividend of $0.67 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.68 annualized dividend and a yield of 1.3%. This is an increase from National HealthCare’s previous quarterly dividend of $0.64. National HealthCare’s dividend payout ratio (DPR) is 61.89%.

Insider Buying and Selling

In other news, Director Lisa Piercey acquired 949 shares of the company’s stock in a transaction on Monday, June 1st. The shares were bought at an average price of $184.26 per share, with a total value of $174,862.74. Following the completion of the acquisition, the director owned 949 shares in the company, valued at $174,862.74. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 13.92% of the stock is owned by corporate insiders.

About National HealthCare

(Free Report)

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.

Further Reading

Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHCFree Report).

Institutional Ownership by Quarter for National HealthCare (NYSEAMERICAN:NHC)

Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.